Stephen S. Whitehead

The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

Martina Beltramello, Katherine L. Williams, Cameron P. Simmons et al. · Cell Host & Microbe · 2010 · 590 citations · Full text

Vaccination, Highly Cross-reactive Antibodies, Enhancing Activity +10

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication <i>in vitro</i> : Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

Ruth A. Karron, Deborah A. Buonagurio, Alice Georgiu et al. · Proceedings of the National Academy of Sciences · 1997 · 413 citations · Full text

Evaluation of a Live, Cold‐Passaged, Temperature‐Sensitive, Respiratory Syncytial Virus Vaccine Candidate in Infancy

Peter F. Wright, Ruth A. Karron, Robert B. Belshe et al. · The Journal of Infectious Diseases · 2000 · 307 citations

Vaccination, Vaccine Safety, Vaccinology +14

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

Anna P. Durbin, Ruth A. Karron, Wellington Sun et al. · American Journal of Tropical Medicine and Hygiene · 2001 · 293 citations

Vaccination, Dengue Virus, Vaccine Development +15

The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model

Beth D. Kirkpatrick, Stephen S. Whitehead, Kristen K. Pierce et al. · Science Translational Medicine · 2016 · 252 citations